GATA2 and gastric adenocarcinoma: In BioTarget [4], we demonstrated how targets of TBX21 and GATA2 can be identified, respectively, for the differentiation of Th1 and Th2 immune cells by analyzing the respective ENCODE ChIP-Seq data over five different TCGA cancer cohort data sets, Stomach Adenocarcinoma (STAD), Breast Invasive Carcinoma (BRCA), Colon Adenocarcinoma (COAD), Lung Adenocarcinoma (LUAD), and Lung Squamous Cell Carcinoma (LUSC).